Log in
Science fiction facilitates the exploration of pressing social, technological, cultural, ethical and philosophical issues, and our research engages with topics such as religious identity and what it means to be human, and also identifies and analyses changes in the way science, as a discourse and practice, has been defined and perceived. Our research, both critical and creative, has had impact through providing cultural enrichment to a range of individuals and groups, transferring the insights gained from this research to a wider audience. The dissemination of our research has challenged social assumptions, as well as created and interpreted cultural capital.
This study details the impact of the first British Library exhibition on science fiction, produced in partnership with the Discovery Channel. The exhibition attracted 114,878 visitors (target attendance was 100,000), far beyond any "core" readership, and featured over 200 books, films, recordings, manuscripts, magazines and objects. Exploring sometimes conflicting ideas of how science fiction developed over 2000 years, and what it does, the exhibition gave a cultural and historical context for science fiction as an international and historically rich form of speculative literature. It also generated new interest amongst diverse audiences — including in libraries, the media, and in schools — and transformed popular perceptions (of both core fans and literary disparagers) of science fiction as a genre, and the role of women in the genre.
Rebecca Stott's research into evolutionary theory (2001-7) has informed public knowledge of the history and philosophy of science. Both her fiction and her creative non-fiction make comparatively unfamiliar aspects of early evolutionary theory accessible to the general reader, and have thus enhanced understanding of science as well as scientists' understanding of culture. Stott founded a tradition of exploring science-literature intersections within our department which has been carried forward by our creative writers Katy Price and Laura Dietz.
Given ever increasing demands on scarce health care resources, decisions on whether to fund new health care interventions, particularly pharmaceuticals, are increasingly being informed by evidence on cost-effectiveness in terms of the cost per Quality Adjusted Life year (QALY). The SF-6D health index method is used internationally for calculating QALYs using patient reported health from clinical trials and other sources. The development of the SF-6D contributes to health policy and welfare via a more efficient allocation of scarce health care resources and has significant commercial benefit. The health policy and welfare benefits arise from the use of the SF-6D in the assessment of the cost effectiveness by health services and regulatory agencies around the world (including Australia, Canada, China, Scotland, Netherlands and Norway) thus facilitating decisions on the most efficient use of limited health care resources. The SF-6D is freely available to non-commercial bodies, including researchers and policy makers. Commercial benefits come from the licensing of the measure to pharmaceutical companies and others to assess the cost effectiveness of their products, with 460 licences sold globally since 2008, and a further 521 licences distributed on a non-commercial basis to public sector and charitable status organisations.
This case study focuses on the impact of the research of one member of the UCL English Department, John Mullan. It describes the impact of his introduction of techniques of narrative analysis to the general reader and to secondary school teachers and students. This has involved making accessible to the general public an informed historical understanding of the development of English fiction, communicating techniques of critical reading that assist the appreciation of both canonical and contemporary novels. This has meant acting as a bridge between contemporary writers and readers, and communicating via print, radio and television the history of the genre. It has also meant delivering the benefits of a specialised critical vocabulary to teachers teaching fiction at secondary school level.
The decision about whether to fund new health care interventions is increasingly being informed by evidence of cost-effectiveness in terms of the cost per Quality Adjusted Life Years (QALY). The SF-6D health index is widely used internationally for calculating QALYs from patient reported health outcomes collected in clinical trials and other surveys. It contributes to health system efficiency from being used by health technology agencies around the world (including Australia, Canada, England, Scotland, Ireland and Norway) to calculate QALYs to facilitate decisions about the most efficient use of limited health care resources. The SF-6D is freely available to non-commercial bodies, including researchers and policy makers. Commercial benefits come from the licensing of the measure to pharmaceutical companies, health insurers and others to assess the cost-effectiveness of their products with 460 licenses being sold since 2008. A further 521 licenses are distributed on a non-commercial basis to academic researchers, public sector and charitable organisations.